Movement Alert｜MEDBOT-B Rises 6.63% in Regular Trading, First-Ever Half-Year Profit Continues to Boost Sentiment

Market Focus07-27

On July 27, MEDBOT-B rose 6.63% in regular trading, trading at 21.28 HKD/share, with turnover of approximately 29.60 million HKD.

On the news front, the company recently issued a positive profit alert, forecasting net profit of approximately RMB 28 million to 40 million for the first half, compared with a net loss of RMB 115 million in the same period last year, marking its first-ever half-year profitability. First-half revenue is expected to surge 200% to 230% year-over-year, driven by strong sales of its core Toumai laparoscopic surgical robot across domestic and overseas markets, with overseas revenue growing over 450% year-over-year.

Additionally, Toumai global commercial orders have exceeded 300 units and installations have surpassed 200 units worldwide. The product also obtained EU CE certification for remote surgery across all surgical departments, becoming the first remote surgical robot to receive such approval. Gross profit margin improved by more than 15 percentage points, while operating expense ratios declined significantly, reflecting enhanced operational efficiency.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122623616?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-27 09:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122623616","market":"us","top_or_hot":-1,"title":"Movement Alert｜MEDBOT-B Rises 6.63% in Regular Trading, First-Ever Half-Year Profit Continues to Boost Sentiment","media":"Market Focus","content":"<p><p>On July 27, MEDBOT-B rose 6.63% in regular trading, trading at 21.28 HKD/share, with turnover of approximately 29.60 million HKD.</p><p>On the news front, the company recently issued a positive profit alert, forecasting net profit of approximately RMB 28 million to 40 million for the first half, compared with a net loss of RMB 115 million in the same period last year, marking its first-ever half-year profitability. First-half revenue is expected to surge 200% to 230% year-over-year, driven by strong sales of its core Toumai laparoscopic surgical robot across domestic and overseas markets, with overseas revenue growing over 450% year-over-year.</p><p>Additionally, Toumai global commercial orders have exceeded 300 units and installations have surpassed 200 units worldwide. The product also obtained EU CE certification for remote surgery across all surgical departments, becoming the first remote surgical robot to receive such approval. Gross profit margin improved by more than 15 percentage points, while operating expense ratios declined significantly, reflecting enhanced operational efficiency.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜MEDBOT-B Rises 6.63% in Regular Trading, First-Ever Half-Year Profit Continues to Boost Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜MEDBOT-B Rises 6.63% in Regular Trading, First-Ever Half-Year Profit Continues to Boost Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-27 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 27, MEDBOT-B rose 6.63% in regular trading, trading at 21.28 HKD/share, with turnover of approximately 29.60 million HKD.</p><p>On the news front, the company recently issued a positive profit alert, forecasting net profit of approximately RMB 28 million to 40 million for the first half, compared with a net loss of RMB 115 million in the same period last year, marking its first-ever half-year profitability. First-half revenue is expected to surge 200% to 230% year-over-year, driven by strong sales of its core Toumai laparoscopic surgical robot across domestic and overseas markets, with overseas revenue growing over 450% year-over-year.</p><p>Additionally, Toumai global commercial orders have exceeded 300 units and installations have surpassed 200 units worldwide. The product also obtained EU CE certification for remote surgery across all surgical departments, becoming the first remote surgical robot to receive such approval. Gross profit margin improved by more than 15 percentage points, while operating expense ratios declined significantly, reflecting enhanced operational efficiency.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1122623616","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122623616","pubTimestamp":1785116562,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 27, MEDBOT-B rose 6.63% in regular trading, trading at 21.28 HKD/share, with turnover of approximately 29.60 million HKD.On the news front, the company recently issued a positive profit...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"走势警报|MEDBOT-B 常规交易上涨 6.63%，首次半年盈利继续提振市场情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"On July 27, MEDBOT-B rose 6.63% in regular trading, trading at 21.28 HKD/share, with turnover of approximately 29.60 million HKD.On the news front, the company recently issued a positive profit alert, forecasting net profit of approximately RMB 28 million to 40 million for the first half, compared with a net loss of RMB 115 million in the same period last year, marking its first-ever half-year profitability. First-half revenue is expected to surge 200% to 230% year-over-year, driven by strong sales of its core Toumai laparoscopic surgical robot across domestic and overseas markets, with overseas revenue growing over 450% year-over-year.Additionally, Toumai global commercial orders have exceeded 300 units and installations have surpassed 200 units worldwide. The product also obtained EU CE certification for remote surgery across all surgical departments, becoming the first remote surgical robot to receive such approval. Gross profit margin improved by more than 15 percentage points, while operating expense ratios declined significantly, reflecting enhanced operational efficiency.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122623616","isCrawlerRequest":true}